-
Syros Prices of $75.6 Million Public Offering of Common Stock
Post on 1/20/21
-
AVEO Oncology Announces Incremental $10M Loan
Post on 1/20/21
-
Here's Why Bristol Myers Squibb's Partners Think 2021 Could Be Prosperous
Post on 1/20/21
-
Moderna CEO's 9 Words That Could Mean Billions for the Biotech
Post on 1/20/21
-
Fulcrum Therapeutics Prices of Public Offering of Common Stock
Post on 1/19/21
-
TCR Therapeutics Prices Public Offering of $140.0 Million of Common Stock
Post on 1/19/21
-
Editas Medicine Announces Offering of Common Stock
Post on 1/19/21
-
Syros Announces Proposed Offering of Common Stock
Post on 1/19/21
-
Fulcrum Therapeutics Proposes Public Offering of Common Stock
Post on 1/19/21
-
Thermo Fisher Scientific to Acquire Mesa Biotech
Post on 1/19/21
-
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement
Post on 1/19/21
-
Royalty Pharma Acquires Royalty Interest in Seltorexant From Minerva Neurosciences
Post on 1/19/21
-
Minerva Neurosciences and Royalty Pharma Announce Sale of Seltorexant Royalty for up to $155 Million
Post on 1/19/21
-
TCR² Therapeutics Proposes Public Offering of Common Stock
Post on 1/19/21
-
Beam Therapeutics Announces $260 Million Common Stock Investment from Multiple Investors
Post on 1/19/21
-
Verve Therapeutics Closes $94 Million Series B
Post on 1/19/21
-
Can the Pfizer and Moderna Vaccines Beat the New Coronavirus Strains?
Post on 1/19/21
-
Better Buy: Novavax vs. Moderna
Post on 1/19/21
-
This Is the Best News Yet for Moderna's COVID Vaccine
Post on 1/19/21
-
Invitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia Project
Post on 1/15/21
-
Moderna to Test Coronavirus Vaccine Booster Shot in New Clinical Trial
Post on 1/15/21
-
Orthus Health Partners With Healbright To Expand Mental Health Offering
Post on 1/14/21
-
Is Moderna Stock Overvalued?
Post on 1/14/21
-
Aldeyra Therapeutics Prices Public Offering of Common Stock
Post on 1/13/21
-
Disc Medicine Appoints William White to its Board of Directors
Post on 1/13/21
Boston
